Table 2. Characteristics of benign soft tissue tumors.
| Patient No. | Sex/Age | Histology | Location | Volume (cm3) | Dose (Gy/fx) | BED (Gy3) | F/Ua) (M) |
|---|---|---|---|---|---|---|---|
| 1 | F/50 | Fibromatosis | Buttock | 38.4 | 33/3 | 92 | 128 |
| 2 | M/32 | Giant cell tumor | Paraspinal | 143.8 | 42/3 | 143 | 102 |
| 3 | M/32 | Neurofibroma | Chest wall | 9.5 | 24/3 | 53 | 86 |
| 4 | M/37 | Hemangioblastoma | Paraspinal | 11.2 | 24/3 | 53 | 73 |
| 5 | M/56 | Neurogenic tumor | Paraspinal | 33.7 | 27/3 | 65 | 20b) |
Abbreviations: BED, biologically equivalent dose; F/U, follow-up after SBRT; M, months
a)All patients achieved local control during follow-up.
b)Patient 5 died from hepatocellular carcinoma at 20 months after SBRT.